Good morning everyone and how are you today Another balmy day is unfolding over the Pharmalot campus where the remaining short person is off to another busy at a new schoolhouse Now that the chaos has past we can indulge in our ritual cup of stimulation and look toward what is shaping up to be another busy day No doubt you can somehow relate So time to get started Here is the latest lineup of interesting items Hope you conquer the world and do stay in touch Meanwhile Genzyme will charge about the same for its new Cerdelga drug for Gauchers disease as it does for its older Cerezyme treatment even though manufacturing costs for the new pill are less than what it costs to make the older one The US Department of Health and Human Services will provide up to  million to Mapp Pharmaceutical to accelerate development and testing of its Ebola drug and the Kentucky Horse Racing Commission is researching ways to bolster regulatory oversight of drug compounders following several episodes in which compounded medicines were linked to horse deaths and failed drug tests